Clinical Trial Update: The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether zinc, beta-carotene, and vitamin D3 influence preterm birth risk through placental inflammatory pathways; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Beta-carotene (beta-carotene)
• Vitamin D3 (Cholecalciferol)
• ZINC (Zinc chloride)

Snippet

Sponsor: Indonesia University | Conditions: PreTerm Birth | Phase 4 | Status: COMPLETED